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Abstract
Introduction: Hepatitis B is a serious potentially fatal hepatocellular disease caused by the hepatitis B virus. In the
fishing communities of Lake Victoria Uganda, the hepatitis B virus infection burden is largely unknown. This study
assessed the prevalence and incidence of hepatitis B in these communities.
Methods: This was a retrospective cohort study that tested serum samples collected from 13 to 49-year-old study
participants that were residing in two Ugandan Lake Victoria fishing communities of Kasenyi (a mainland) and
Jaana (an island). The samples were collected between 2013 and 2015 during the conduct of an HIV
epidemiological cohort study in these communities. A total of 467 twelve-month follow-up and 50 baseline visit
samples of participants lost to follow-up were tested for hepatitis B serological markers to determine prevalence. To
determine hepatitis B virus incidence, samples that were hepatitis B positive at the follow-up visit had their baseline
samples tested to identify hepatitis B negative samples whose corresponding follow-up samples were thus incident
cases.
Results: The baseline mean age of the 517 study participants was 31.1 (SD ± 8.4) years, 278 (53.8%) of whom
were females. A total of 36 (7%) study participants had hepatitis B virus infection, 22 (61.1%) of whom were
male. Jaana had a higher hepatitis B virus prevalence compared to Kasenyi (10.2% vs 4.0%). In total, 210 (40.6%)
study participants had evidence of prior hepatitis B virus infection while 48.6% had never been infected or
vaccinated against this disease. A total of 20 (3.9%) participants had results suggestive of prior hepatitis B
vaccination. Hepatitis B incidence was 10.5 cases/100PY (95% CI: 7.09–15.53). Being above 25 years of age and
staying in Jaana were significant risk factors for hepatitis B virus acquisition (AOR 1.6, 95% CI: 1.1–2.2; p < 0.01
and 1.4, 95% CI: 1.1–1.8; p < 0.01 respectively).
Conclusion: Hepatitis B virus incidence in Lake Victoria fishing communities of Uganda is very high, particularly
in the islands. Interventions to lower hepatitis B virus transmission in these communities are urgently needed.
Keywords: Hepatitis B prevalence, Hepatitis B incidence, HBV prevalence, HBV incidence, Lake Victoria fishing
communities
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Introduction
Hepatitis B is a viral infection caused by the hepatitis B
virus (HBV) which leads to acute and chronic liver disease.
Chronic liver disease can lead to cirrhosis and associated
life-threatening complications such as hepatocellular car-
cinoma [1]. The World Health Organization (WHO) re-
ported that in 2015, an estimated 887,000 people died
from HBV infection-related complications worldwide [2].
Transmission of HBV occurs primarily through percu-
taneous or mucosal exposure to infected blood or other
body fluids [3]. In highly endemic areas, HBV is mainly
spread at birth from mother to child or during the first
5 years of life from an infected to an uninfected child
[4]. It is estimated that up to 90% of perinatal HBV in-
fections, 20 to 60% of infections occurring between the
ages of 1 to 5 years, and 5 to 10% of infections occurring
above 5 years become chronic [5]. In low-endemicity
areas, most HBV infections occur in adolescents and
young adults primarily through sexual or percutaneous
exposure [6].
The global prevalence of HBV is estimated at 3.5–3.9%
but with wide regional variations [2, 7, 8]. Sub-Saharan
Africa has been reported to have the highest HBV en-
demicity with more than 8% of the adult population esti-
mated to be chronically infected [8]. According to the
Uganda Population-based HIV Impact Assessment
(UPHIA) 2016–2017 national serosurvey, HBV infection
prevalence among Ugandan adults was 4.3% with the
northern region of the country having the highest preva-
lence (4.6%) and the southwest the lowest (0.8%) [9]. In
2015, an estimated 52% of Ugandan adults had evidence
of previous or ongoing HBV infection [10].
Adults in the Lake Victoria fishing communities were
reported to engage in high-risk sexual behaviors which
put them at an increased risk of acquiring sexually trans-
mitted infections [11]. Indeed, high HIV prevalence and
incidence rates of 22 to 28% and 3.4–4.9/100 person-
years at risk respectively have been reported in these
communities [11–14]. Since HIV and HBV share routes
of transmission, a high proportion of adults at risk for
HIV infection in the Lake Victoria fishing communities
might also be at risk of acquiring HBV [15, 16]. Whereas
several studies have reported on the prevalence of HBV
infection in different Ugandan populations, we are not
aware of any that have specifically targeted the Lake
Victoria fishing communities. This study therefore
sought to investigate the prevalence, incidence, and risk
factors of HBV infection among the Lake Victoria fish-
ing communities of Uganda.
Methods
Study design and population
This was a retrospective study that used archived serum
samples collected during an HIV epidemiological cohort
study. The cohort study was conducted in 10 fishing
communities of Lake Victoria, Uganda between 2013
and 2015. The study communities were purposively se-
lected based on lack of participation in previous HIV
epidemiological studies, geographical representation, and
their large size. Our previously conducted research sug-
gested that limited or no risk screening was necessary as
HIV risk in fishing communities was widespread [11–
13]; Communities were selected based on size and no
HIV risk criteria were used to select study participants.
The study recruited 13 to 49-year-old males and females
randomly selected from an updated census database
conducted for all households in these communities be-
fore the start of the cohort study. Participants were resi-
dents in these communities for at least 6 months at the
time the cohort study was conducted. Apart from age
and residency eligibility, no other inclusion or exclusion
criteria were used to select study participants. For this
retrospective HBV study, samples from two of the com-
munities that had the highest study participant retention
rate after 12 months of follow-up were used to allow for
more power to calculate incidence and to reduce selec-
tion bias that could be caused by volunteer loss to follow
up. These two communities selected were Kasenyi lo-
cated on the mainland in Wakiso district and Jaana an
island in Kalangala district which had 12-month reten-
tion of 93.9 and 93.4% respectively. To further minimize
subject selection bias, all volunteer samples collected
from the two communities during the conduct of the
parent HIV epidemiological cohort study were used.
Hepatitis B testing and determination of HBV status
Each serum sample was tested on three different HBV tests
namely, HBV surface antigen (HBsAg), HBV core anti-
bodies (anti-HBc), and HBV surface antibodies (anti-HBs).
Testing was done from the MRC/UVRI & LSHTM Uganda
Research Unit Clinical Laboratory using the Cobas e 411
analyzer (Roche Diagnostics, Mannheim, Germany) and the
Elecsys HBsAg II, Anti-HBc II, and Anti-HBS II kits. The
HBV results were categorized into one of five groups: 1) ac-
tively (acute or chronic) infected (HBsAg positive), 2) previ-
ously infected or resolved infection (HBsAg negative, anti-
HBc & anti-HBs positive), 3) vaccinated (anti-HBs positive,
HBsAg & anti-HBc negative) or 4) susceptible or HBV
naive (HBsAg, anti-HBc & anti-HBs negative). A fifth group
included those with indeterminate results (HBsAg negative,
anti-HBs negative, anti-HBc positive) whose categorization
can be either of four states namely, resolved infection (most
common), false-positive anti-HBc, low-level chronic infec-
tion, or resolving acute infection [17]. Samples in this group
were retested on all three HBV tests to rule out false-
positive anti-HBc results and thereafter categorized as re-
solved or previously infected if still anti-HBc positive. The
anti-HBs titer cut-off value was 10 IU/L.
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Determination of hepatitis B virus prevalence and
incidence
To determine HBV incidence, samples were tested at two
time points namely at baseline and follow-up visits which
were approximately 12months apart. Initially, all samples
from the follow-up visit (n = 467) of the parent cohort
study were tested. After this testing, samples whose results
were consistent with active or resolved infection had their
corresponding baseline samples tested. Follow-up samples
whose corresponding baseline samples were negative for
all HBV assays were subsequently identified as HBV inci-
dent cases. Samples that were negative by all HBV assays
at the follow-up visit did not have their corresponding
baseline sample tested. To better estimate HBV preva-
lence at baseline, we also tested baseline samples from
those study participants who were not seen at the follow-
up visit because they were lost to follow up (n = 50). Per-
son time was calculated as the amount of time between
test visits, with those incident cases estimated as having
acquired HBV at the midpoint of their follow up time. We
report baseline prevalence as a percent (with binomial
standard errors), and incidence as cases per 100 person
years with 95% confidence intervals.
Data analysis
Bivariate analyses were used to assess the potential associ-
ation between exposure variables (demographics and socio-
behavioural characteristics) and HBV infection using chi-
square tests and unadjusted logistic regression models. Fac-
tors that were significant at bivariate analysis with p ≤ 0.2
were added in the multivariable logistic regression model to
estimate the adjusted odds ratios. Exposure variables were
added to the model one at a time and their effect on model
adequacy determined by the log-likelihood tests to compare
the fit of the models with and without the variable. Con-
founding was assessed by the change of magnitude in the
effect measure with the addition and removal of new vari-
ables. In the final adjusted model, variables with a p-value
< 0.05 were taken to be associated with the risk of HBV in-
fection. Data analysis was performed using Stata® 14 (Stata-
Corp, College Station, Texas).
Results
Study participant characteristics
A total of 517 participant samples were tested for HBV
of which 272 (52.6%) were from Kasenyi landing site and
245 (47.4%) from Jaana Island. Of these, 278 (53.8%)
were from female participants. The mean and median
age of the study participants was 31.1 (SD ± 8.4) and 30
(IQR 25–37) years respectively. About a quarter (24.2%)
of the participants were aged 13–24 years and the rest
were above 25 years. The majority (52.6%) of the partici-
pants were engaged in fishing, fishing-related business,
or trade.
Hepatitis B prevalence
Of the 517 study participants, 246 (47.6%, SE: 2.2%) had
evidence of exposure to HBV, including 36 (7.0%, SE:
1.1%) with active (acute or chronic) infection and 210
(40.6%, SE: 2.2%) with resolved or prior infection
(Table 1). Active hepatitis B infection prevalence in
Jaana Island was about 2.5 times that of Kasenyi main-
land (10.2% vs 4.0%). None of the participants engaged
in farming, those whose occupation was categorised as
housewives, or who reported not having sexual partners
within the last 12 months had active HBV infection.
Prevalence of active HBV infection was highest in partic-
ipants working in bars and lodges (10.6%) followed by
those in fish or fish related business (7.8%). Active HBV
infection among married participants was twice that of
unmarried ones.
Study participants involved in fishing or fish related
business had the highest prior exposure to HBV (47.9%)
while those employed in farming had the lowest (26.1%).
Altogether, 251 (48.5%) of the study participants had no
evidence of active infection with, prior exposure to, or
vaccination against HBV. A total of 20 (3.9%) of the
study participants had results indicative of HBV vaccin-
ation (anti-HBs positive, anti-HBc and HBsAg negative),
majority 14 (70%) of whom were female and from Kase-
nyi mainland 15 (75%). Those engaged in farming also
had the highest proportion of participants (17.4%) with
evidence of prior HBV vaccination while those employed
in bars and lodges had none in this category.
Hepatitis B incidence
For the determination of incidence, we tested 191 base-
line samples of study participants that were HBsAg or
anti-HBc positive at follow-up (Fig. 1). Of these, 25 sam-
ples were negative on all baseline HBV tests, represent-
ing the incident cases. Together with the 229 samples
that were HBV negative at both the baseline and the
follow-up visit, we thus observed 25 incident cases over
238-person years to obtain an incidence rate of 10.5
cases/100PY (95% CI: 7.09–15.53).
In bivariate analysis, being above 25 years of age and
staying in Jaana Island were significantly associated with
HBV incidence and were included in our assessment of
predictors of HBV infection. In the multivariable analysis
(Table 2) -adjusted for occupation, marital status, sexual
partners, and condom use, being above 25 years was as-
sociated with a 1.6 times increase in the odds of acquir-
ing HBV (95% CI 1.1–2.2; p < 0.01) and staying in Jaana
Island was associated with a 1.4 times increase in the
same odds (95% CI 1.1–1.8; p < 0.01). Having a sexual
partner in the last 12 months or being HIV positive were
borderline significant risk factors for the acquisition of
HBV in the bivariate analysis but non-significant after
multivariable analysis. Occupation, marital status, having
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a new sexual partner in the last 12 months, condom use
in the last 12 months, and having syphilis were not asso-
ciated with HBV incidence.
Discussion
In this study, we investigated the prevalence, incidence, and
risk factors of HBV acquisition in selected fishing
communities of Lake Victoria, Uganda. Our results show
that 7% of the study population in these communities was
infected with the HBV and about 41% had evidence of prior
infection with this virus. The results further showed that
HBV incidence in these communities was very high at over
10.5 cases per 100 person-years and that incident infection
is associated with living on an isolated island community.
Table 1 Hepatitis B prevalence in Lake Victoria fishing communities
Characteristic Total Active HBV infection Resolved HBV infection HBV vaccinated HBV naive
N n (%) n (%) n (%) n (%)
517 36 (7.0) 210 (40.6) 20 (3.9) 251 (48.6)
Age (years)
13–24 125 7 (5.6) 33 (26.4) 6 (4.8) 79 (63.2)
25+ 392 29 (7.4) 177 (45.2) 14 (3.6) 172 (43.9)
Sex
Female 278 14 (5.0) 108 (38.8) 14 (5.0) 142 (51.1)
Male 239 22 (9.2) 102 (42.7) 6 (2.5) 109 (45.60
Occupation
Fishing & related 219 17 (7.8) 105 (47.9) 7 (3.2) 90 (41.1)
Trade/Business 53 4 (7.5) 18 (34.0) 1 (1.9) 30 (56.6)
Bar/Lodge 47 5 (10.6) 17 (36.2) 0 (0.0) 25 (53.2)
Farming 23 0 (0.0) 6 (26.1) 4 (17.4) 13 (56.5)
Housewife 46 0 (0.0) 17 (37.0) 3 (6.5) 26 (56.5)
Others 129 10 (7.8) 47 (36.4) 5 (3.9) 67 (51.9)
Marital status
Not Married 204 9 (4.4) 78 (38.2) 7 (3.4) 110 (53.9)
Married monogamous 239 21 (8.8) 102 (42.7) 11 (4.6) 105 (43.9)
Married polygamous 74 6 (8.1) 30 (40.5) 2 (2.7) 36 (48.6)
Sexual partners in the past 12months
No 79 0 (0.0) 27 (34.2) 3 (3.8) 49 (62.0)
Yes 438 36 (8.2) 183 (42.8) 17 (3.9) 202 (46.1)
New sexual partner in the past 12months
No 297 29 (9.8) 121 (40.7) 13 (4.4) 134 (45.1)
Yes 141 7 (5.0) 62 (44.0) 4 (2.8) 68 (48.2)
Condom use in the past 12months
No 287 22 (7.7) 111 (38.7) 16 (5.6) 138 (48.1)
Yes 151 14 (9.3) 72 (47.7) 1 (0.7) 64 (42.4)
Community
Mainland 272 11 (4.0) 95 (34.9) 15 (5.5) 151 (55.5)
Island 245 25 (10.2) 115 (46.9) 5 (2.0) 100 (40.8)
Syphilis
Positive 39 4 (10.3) 18 (46.2) 3 (7.7) 14 (35.9)
Negative 474 32 (6.8) 189 (39.9) 17 (3.6) 236 (49.8)
HIV
Positive 119 11 (9.2) 58 (48.7) 2 (1.7) 48 (40.3)
Negative 394 25 (6.3) 149 (37.8) 18 (4.6) 202 (51.3)
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The 7.0% active HBV infection prevalence observed in
our study is slightly lower than that reported by several
studies conducted in Uganda before 2016. These studies
reported a prevalence of between 8.1% in health care
workers from the centrally located Mulago national referral
hospital to 14.9% in adults from Northern Uganda [18–
21]. It was also lower than the 2005 national HBV preva-
lence of 10.6% obtained from a hepatitis B serosurvey that
was incorporated into the Uganda HIV/AIDS Sero-
Behavioural Survey but comparable to the 6.2% reported
by the same survey for the Central region where our study
population is located [10]. Our study’s prevalence was
however substantially higher than what has been reported
in more recent studies including the UPHIA 2016–2017
national serosurvey and a 2016 HBV modelling study
which estimated a national HBV prevalence of 4.3 and
5.5% respectively [3, 9]. In the area where our study com-
munities are located, the HBV prevalence reported by the
UPHIA 2016–2017 national serosurvey was 1.6% suggest-
ing that as of 2015 when samples for our study were col-
lected, the HBV prevalence in the Lake Victoria fishing
communities was about four times higher than that of the
general population surrounding these communities.
Nearly half (47.6%) of the population was either previ-
ously exposed to or actively infected with HBV and 3.9%
had serological evidence of HBV vaccination. The
remaining 48.5% had never been infected or vaccinated
against HBV. These results suggest that about half of the
population in the fishing communities of Lake Victoria
in Uganda may be susceptible to HBV infection. Given
the very high HBV incidence we observed, universal
hepatitis B vaccination which was rolled out in 2020 by
the Ministry of Health should be prioritised for this
community [22, 23].
Our data indicated that HBV prevalence was signifi-
cantly higher in the island community compared to the
Fig. 1 Hepatitis B testing schematic
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mainland community. The national serosurveys of 2005
and 2016/17 also reported large variations in HBV
prevalence across the country even though the reasons
for this variance were not conclusively explained [9, 10].
However, in the Central region where our study’s two
fishing communities are located, the HBV prevalence
was reported at 1.6% by the UPHIA 2016–2017 national
serosurvey which is substantially lower than what our
study found. We compared the hepatitis B infection risk
factors across the two study communities using the
HBV risk factors that were collected but none could ex-
plain the difference in HBV acquisition risk between our
study communities.
A very high HBV incidence of 10.5 cases/100PY was
observed in our study population. To the best of our
knowledge, Hepatitis B virus incidence has never been
reported before in this population. Indeed, there is a
paucity of data on HBV incidence in the various
Table 2 Hepatitis B acquisition risk factors in Lake Victoria fishing communities
Characteristic Unadjusted Risk Ratios Adjusted Risk Ratios
RR 95%CI P-value RR 95%CI P-value
Gender
Female 1 (Ref)
Male 1.2 (0.9–1.5) 0.19
Age (years)
13–24 1 (Ref)
25+ 1.6 (1.2–2.3) 0.004 1.6 (1.1–2.2) 0.01
Occupation
Trade/business 1 (Ref)
Fishing & related 1.3 (0.9–2.1) 0.20
Bar/lodge 1.1 (0.6–2.0) 0.62
Farming 0.6 (0.3–1.6) 0.26
Housewife 0.9 (0.5–1.7) 0.47
Others 1.1 (0.7–1.7) 0.65
Marital status
Not Married 1 (Ref)
Married monogamous 1.2 (0.9–1.6) 0.18
Married polygamous 1.2 (0.8–1.7) 0.51
Any sexual partners in the past 12months
No 1 (Ref)
Yes 1.5 (1.0–2.2) 0.06
New sexual partner in the past 12months
No 1 (Ref)
Yes 1.0 (0.8–1.4) 0.79
Condom use in the past 12months
Yes 1 (Ref)
No 0.8 (0.6–1.1) 0.14
Community
Mainland 1 (Ref)
Island 1.5 (1.1–1.9) 0.003 1.4 (1.1–1.8) 0.01
Syphilis testing at baseline
Negative 1 (Ref)
Positive 1.2 (0.8–1.9) 0.39
HIV testing at baseline
Negative 1 (Ref)
Positive 1.3 (1.0–1.7) 0.06
Kitandwe et al. BMC Public Health          (2021) 21:394 Page 6 of 8
subpopulations of Uganda or the sub-Saharan region in
general. Wahome et al. reported an HBV incidence rate
of 6.0/100 person-years (95% confidence interval [CI],
3.9–9.1) in HIV-1 negative men who have sex with men
in Kenya [24]. Compared to Wahome’s study group
which reported high-risk sexual behaviour, HBV inci-
dence in our study population was nearly twice as high.
The reasons for this high HBV incidence are not clear.
Most HBV infections occurring within the Ugandan
populations have been attributed to sexual contact [10,
25]. Considering that a high HIV incidence that has been
reported before in these fishing communities [11, 12], it
is possible that most HBV transmissions in our study
population also occurred through sexual contact. Sur-
prisingly, there was no statistically significant association
between HBV incidence and condom use or sexual part-
ners in our study. This could be due to the underreport-
ing of these variables by our study participants.
Among the different characteristics of this study popu-
lation that were examined, being above 25 years of age
and staying in Janna Island community were significant
risk factors for the acquisition of HBV after adjusting for
other factors. Similar to what was observed in this popu-
lation with HIV infection, marital status, having a new
sexual partner in the last 12 months, and condom use
were not significant risk factors of transmission of HBV
[11]. Staying in the island community of Jaana carried a
significantly higher risk of acquisition of HBV compared
to staying on the mainland. A possible explanation for
this difference is that there is easier access to better
health facilities on the mainland compared to the island.
Access to health facilities could facilitate the treatment
of sexually transmitted infections which are a risk factor
for the transmission of HBV. Other factors that could
explain this difference in HBV infection risk could be
differences in sexual partners, sexual practices, or risk
behavior. An examination of the available data did not
suggest that there were significant differences in these
factors between the two study sites. However, the per-
centage of study participants that had sexual partners in
the last 12 months was higher in Jaana (92%) compared
to Kasenyi (78%) possibly putting the former at a higher
risk of HBV infection compared to the latter.
Similar to what has been shown for HIV in the fishing
community, there was no association between HBV inci-
dence and occupation [12, 26]. However, it is worth not-
ing that prevalence was highest among the bar workers
which is in concordance with what was reported for
HIV. This is likely because bar workers in the Lake
Victoria fisherfolk community usually also engage in
commercial sex work, a high-risk factor for the acquisi-
tion of HBV [26].
This study had some limitations. Only two study com-
munities were selected as representative communities of
the Lake Victoria fishing communities. Whereas both an is-
land and a mainland community with the best retention
were chosen from a 10-community study (to allow for
more power to calculate incidence), they may not have
been an accurate representation of the different Lake
Victoria fishing communities. Secondly, the study popula-
tion did not include young children below 13 years who
might have a lower HBV prevalence due to the introduc-
tion of routine infant hepatitis B virus vaccination in the
Uganda national immunisation program [10]. Given that
our study participants were above 13 years, born before this
vaccination program was instituted, our results do not re-
flect the impact of this intervention on HBV prevalence
and incidence in these communities. We also recognize
that our sample size was modest, and with 254 volunteers
and 25 incident cases of HBV identified, we have limited
power to see correlates of incidence, were they to exist.
Lastly, some risk factors for the acquisition of HBV such as
a history of blood transfusion, tattooing, intravenous drug
use, and sexually transmitted infections apart from syphilis
were not examined because they were not collected in the
parent cohort study. Among our study population, how-
ever, sexually transmitted infections would be of most rele-
vance and possibly of significant impact on the study
outcomes considering that blood transfusion, tattooing,
and injection drug use is uncommon in these communities.
Conclusion
In conclusion, the HBV incidence in Lake Victoria fish-
ing communities of Uganda is very high, particularly in
the island communities. Factors contributing to a higher
HBV incidence in the Island communities compared to
the mainland need to be investigated further. The major-
ity of the population in the fishing communities of Lake
Victoria is susceptible to HBV infection and would
therefore benefit from prevention information and vac-
cination against this infection.
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